Mobidiag has signed an agreement with Ginolis, knowledgeable in assembly automation and high precision liquid handling solutions. Through the implementation of production lines from Ginolis, Mobidiag will be able to answer the needs in molecular diagnostics for routine use and anticipate the production of upcoming Novodiag test cartridges.
Novodiag disposable cartridge for diagnostics of infectious diseases
Launched in December 2017, the Novodiag solution allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results in about an hour.
“The innovative Novodiag cartridge has been developed at Mobidiag thanks to the combination of multidisciplinary teams and expertise. The cartridge includes state-of-the-art technologies such as qPCR and microarray, bringing with them some specific requirements and constraints. We then needed to successfully automate our processes and move from a small scale production capacity to industrial volumes without compromising quality and costs. Thanks to its cutting-edge modular platforms and expertise in diagnostics processes, we are confident that Ginolis will bring the most relevant solution to support us in our growing activity”, said Tuomas Tenkanen, CEO at Mobidiag.
The manufacturing solution developed for Mobidiag is based on Ginolis’ modular Xanthia automation platform. In addition to Ginolis’ patented dispensing technology, the line is equipped with laser welding, precision assembly, ultrasonic welding and line confocal imaging (LCI) for quality inspection.
Antibiotic resistance is one of the greatest threats to the world's health. According to the World Health Organization, the number of antibiotic-resistant bacteria grows at an alarming rate worldwide and all efforts should be taken to stop this development. Fast and reliable diagnostics are needed to detect resistance and thereby reduce the use of antibiotics.